H Lundbeck has appointed Ulf Wiinberg as new president and CEO of the company, effective June 1, 2008.
Subscribe to our email newsletter
Ulf Wiinberg will be leaving the US pharmaceutical company Wyeth, where he has been responsible for two areas – Strategic oversight of Wyeth’s biopharma activities and as president of Wyeth Europe, Middle East, Africa and Canada.
Per Wold-Olsen, chairman of Lundbeck’s supervisory board, said: “Ulf Wiinberg is uniquely qualified to handle the challenges that Lundbeck faces in the short term, and with his broad experience he can contribute to meeting the strategic challenges that we face in the long term.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.